Preferences regarding antibiotic treatment and the role of antibiotic resistance: A discrete choice experiment
- PMID: 33080314
- DOI: 10.1016/j.ijantimicag.2020.106198
Preferences regarding antibiotic treatment and the role of antibiotic resistance: A discrete choice experiment
Abstract
Objectives: To identify preferences of the Swedish public regarding antibiotic treatment characteristics and the relative weight of antibiotic resistance in their treatment choices.
Methods: A questionnaire including a discrete choice experiment questionnaire was answered by 378 Swedish participants. Preferences of the general public regarding five treatment characteristics (attributes) were measured: contribution to antibiotic resistance, cost, side effects, failure rate and treatment duration. Latent class analysis models were used to determine attribute-level estimates and heterogeneity in preferences. Relative importance of the attributes and willingness to pay for antibiotics with a lower contribution to antibiotic resistance were calculated from the estimates.
Results: All attributes influenced participants' preferences for antibiotic treatment. For the majority of participants, contribution to antibiotic resistance was the most important attribute. Younger respondents found contribution to antibiotic resistance more important in their choice of antibiotic treatments. Choices of respondents with lower numeracy, higher health literacy and higher financial vulnerability were influenced more by the cost of the antibiotic treatment. Older respondents with lower financial vulnerability and health literacy, and higher numeracy found side effects to be most important.
Conclusions: All attributes can be considered as potential drivers of antibiotic use by lay people. Findings also suggest that the behaviour of lay people may be influenced by concerns over the rise of antibiotic resistance. Therefore, stressing individual responsibility for antibiotic resistance in clinical and societal communication has the potential to affect personal decision making.
Keywords: Antibiotic resistance; Behaviour; Communication; Discrete choice experiment; Preferences; Sweden.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Exploring the Preferences of the Australian Public for Antibiotic Treatments: A Discrete Choice Experiment.Patient. 2023 Sep;16(5):555-567. doi: 10.1007/s40271-023-00640-z. Epub 2023 Jul 18. Patient. 2023. PMID: 37462880 Free PMC article.
-
The influence of attributes on community preferences regarding antibiotic treatment: evidence from a discrete choice model.Psychol Health Med. 2024 Sep;29(8):1448-1465. doi: 10.1080/13548506.2024.2342589. Epub 2024 May 3. Psychol Health Med. 2024. PMID: 38700271
-
Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?Value Health. 2016 Mar-Apr;19(2):202-9. doi: 10.1016/j.jval.2015.11.004. Epub 2016 Jan 7. Value Health. 2016. PMID: 27021754
-
Societal preferences for funding orphan drugs in China: An application of the discrete choice experiment method.Front Public Health. 2022 Dec 12;10:1005453. doi: 10.3389/fpubh.2022.1005453. eCollection 2022. Front Public Health. 2022. PMID: 36579068 Free PMC article. Review.
-
Patients' preferences for the treatment of anxiety and depressive disorders: a systematic review of discrete choice experiments.J Med Econ. 2020 Jun;23(6):546-556. doi: 10.1080/13696998.2020.1725022. Epub 2020 Feb 24. J Med Econ. 2020. PMID: 32011209
Cited by
-
Cancer patient preferences for traditional Chinese medicine treatment: a discrete choice experiment study.BMC Complement Med Ther. 2025 Jul 2;25(1):218. doi: 10.1186/s12906-025-04937-4. BMC Complement Med Ther. 2025. PMID: 40604987 Free PMC article.
-
Exploring the Preferences of the Australian Public for Antibiotic Treatments: A Discrete Choice Experiment.Patient. 2023 Sep;16(5):555-567. doi: 10.1007/s40271-023-00640-z. Epub 2023 Jul 18. Patient. 2023. PMID: 37462880 Free PMC article.
-
Factors of prescribing phage therapy among UK healthcare professionals: Evidence from conjoint experiment and interviews.PLoS One. 2024 May 7;19(5):e0303056. doi: 10.1371/journal.pone.0303056. eCollection 2024. PLoS One. 2024. PMID: 38713691 Free PMC article.
-
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.Pharmacoeconomics. 2025 Aug;43(8):879-936. doi: 10.1007/s40273-025-01495-y. Epub 2025 May 21. Pharmacoeconomics. 2025. PMID: 40397369 Free PMC article.
-
Phage therapy and the public: Increasing awareness essential to widespread use.PLoS One. 2023 May 18;18(5):e0285824. doi: 10.1371/journal.pone.0285824. eCollection 2023. PLoS One. 2023. PMID: 37200291 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical